Navigation Links
Portable device quickly detects early Alzheimer's
Date:1/16/2008

- administer test to detect and track the cognitive decline associated with the early stages of the disease.

The DETECT device is designed to be administered while a patient is still healthy, tracking any abnormal decreases in the patients cognitive performance over time. If a patients performance declines outside the normal range, the patient would then undergo additional testing and care from a neurologist, neuropsychologist or other specialist.

The DETECT system includes an LCD display in a visor with an onboard dedicated computer, noise reduction headphones and an input device (controller). The display projects the visual aspect of the test, the headphones provide the verbal instructions and the controller records the wearers response.

DETECTs creators have formed a company, called Zenda Technologies (www.zendatech.com), to commercialize the device for MCI, as well as other conditions. Georgia Tech and Emory researchers are exploring other types of cognitive impairment such as Attention Deficit/Hyperactivity Disorder (ADHD) that could be picked up by DETECT. A version of the system designed to detect mild concussions on the sidelines of a football game, during other high-impact sports or on a battlefield is still being tested.


'/>"/>

Contact: Megan McRainey
megan.mcrainey@comm.gatech.edu
404-894-6016
Georgia Institute of Technology
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Portable electricity, life-like prosthetics on the way
2. Smiths Detection to launch a portable diagnostic system for foot-and-mouth disease and avian flu
3. Silex Introduces Worlds First Wireless USB Device Server With Streaming Video and Audio Data Transfer
4. Stanford researchers publish review of US medical device regulation
5. Device prevents potential errors in childrens medications
6. Better protection for biomedial devices could result from Rutgers-Camden research
7. EMD Serono launches easypod, new electronic growth hormone injection device
8. Atmospheric measuring device for understanding smog formation
9. MIT aids creation of neural prosthetic devices
10. IGERT fellows to design biodevices using flexible electronics
11. Researchers developing device to predict proper light exposure for human health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...te (LRI) today named 12 new grant recipients for 2...innovative work across a broad spectrum of lupus r...ovelty, and potential to drive scientific discover...ex disease of systemic lupus. , The 2009 grants ...cross the nation and include interdisciplinary and...
(Date:11/24/2009)...College of Medical Toxicology (ACMT) have signed a...he Journal of Medical Toxicology (JMT), the offi... It was previously published by the University of...Toxicology , an international, peer-reviewed journ...tice of medical toxicology. The quarterly journal...
(Date:11/24/2009)... in Spanish . , The presence of increased b...ry substances in the blood, hinders the loss and m...project of the University of Navarra conducted by ...l of Pharmacy. , The project, entitled "A nutrig...ontrol of body weight and inflammation," examines ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2Experts Urge School Screening of Athletes Hearts 61372 1Experts Urge School Screening of Athletes Hearts 61372 2American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 1American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 2American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 3American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 4American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 5American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 6American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 7While Most Businesses are Laying Off Their Employees The Logo Loft Continues to Hire U S Graphic Designers 61366 1While Most Businesses are Laying Off Their Employees The Logo Loft Continues to Hire U S Graphic Designers 61366 2
..., Robert Seyfarth, a noted expert on monkey commu...olution of a Social Mind" from 5-6:30 p.m., Tuesda... of Delaware. , The lecture will kick off the Uni...which is sponsored by the Center for International...support from colleges and departments across campu...
..., Representatives from four international agencie...icology Program (NTP), today signed a memorandum o...als required for consumer product safety testing w... Canada, Japan and the European Union will yield g...alternative toxicity testing methods that should s...
..., BOSTON (April 27, 2009) In an in vitro study, l...Medicine, researchers discovered how a protein cal... an enzyme complex that alters the structure of ch... is a compacted mass of DNA and protein that make ...he enzyme complex is of interest in the study of c...
Other Biology News:Beyond 'ooh-ooh, aah-aah'-- expert on monkey communication kicks off Darwin series, May 5 2Countries unite to reduce animal use in product toxicity testing worldwide 2Countries unite to reduce animal use in product toxicity testing worldwide 3SUMO protein guides chromatin remodeler to suppress genes 2
(Date:11/24/2009)...and BLENHEIM, Ontario, Nov. 24 /PRNewswire-FirstCa...is acquiring the assets of Hyland Seeds, a divisio...ddition of Hyland Seeds will further expand Dow Ag...anticipates the introduction of SmartStax(TM) in...Trait Technology in corn in 2012. The transactiona...
(Date:11/24/2009)...HANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmace...rk Office (PTO) has allowed the patent application...logy. , NOD technology is a highly effici...nto bio-adhesive nano-particles to enable oral del...s. NOD technology is a platform technology,that ca...
(Date:11/24/2009)...imary efficacy endpoint has been met for patients ...ancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fir...SX: AEZ) (the "Company"), a global biopharmaceutic...gy, today announced positive efficacy data from a ...conjugate, AEZS-108 (formerly AN-152), in patients...
(Date:11/24/2009)...OZEN, Italy, November 24 Health Ro...nadian joint venture with a group of selected,inve...will operate under the,name Health Robotics Canada...h Robotics, i.v. Room of the Future concept, which...STATION(TM), i.v.SOFT(TM), and OMM(TM).,Health Rob...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
... Complimentary Continuing Education Virtual Lectur...ORHEES, N.J., Jan. 20 Current education about Cl...or several reasons. The epidemiology of CDI is cha...more severe disease. In addition, the epidemic st... of states across the United States and worldwide....
... LUDWIGSHAFEN, Germany and ST. LOUIS, Jan. 20 ...nounced a new joint-licensing,agreement to acceler...mba-,based weed control chemistry products. Both p...vative formulations for dicamba for use with herbi...of the agreement were not,disclosed. , Researc...
... Sentrx, a New Jersey dru...company grew the number of pharmacovigilance outso...es for the year increased 25% over 2007. The dome... clinical trial and post-marketing safety, managed...tigation strategies. The company maintained its s...
Other Biology Technology:Clostridium difficile Infection: Current Challenges and Controversies 2BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 2BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 3BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 4Sentrx Exits 2008 with Strong Growth 2Sentrx Exits 2008 with Strong Growth 3
...s constitute the principal excitatory neurotransmi...receptors exist: Ionotropic receptors, and metabot...e oligomeric complexes of various subunits (GluR1-...cium channels. Metabotropic glutamate receptors ar...
PIP Beads di-C6 PtdIns(4,5)P2 from Echelon Biosciences Inc.
Mouse Anti-D-Dimer Antibody, Unconjugated from HyTest Ltd.
...ogen corresponds to amino acids 2-105 from human S...has been successfully used in Western blot, immuno... By Western blot, this antibody detects an ~ 60 kD...s also been used in immunoprecipitation and immuno...
Biology Products: